Dana Farber Cancer Insititute is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
Dana Farber Cancer Insititute has participated in 1 clinical trials.
Therapeutic areas: Advanced Soft-tissue Sarcoma, Advanced Epithelioid Sarcoma.
Sponsors: Epizyme, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Boston
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana Farber Cancer Insititute has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Farber Cancer Insititute has 1 clinical trials on record. Their work covers Advanced Soft-tissue Sarcoma, Advanced Epithelioid Sarcoma.
Dana Farber Cancer Insititute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.